Arcutis Announces Acceptance of Late Breaking Abstract in Atopic Dermatitis Among Five New Topical Roflumilast Data Being Presented at the American Academy of Dermatology Annual Meeting
04 mars 2024 08h00 HE
|
Arcutis Biotherapeutics, Inc.
Arcutis today announced five presentations at the 2024 American Academy of Dermatology (AAD) annual meeting.
BMS Attributes Sotyktu Falling Short of Growth Expectations to Access, but Recent Spherix Global Insights’ Data Suggest Safety Concerns Are More of a Barrier to Increased Uptake
07 déc. 2023 12h01 HE
|
Spherix Global Insights
Exton, PA, Dec. 07, 2023 (GLOBE NEWSWIRE) -- While access took the forefront of BMS’ response to Sotyktu (deucravacitinib) not meeting growth expectations during the company’s Q3 earnings call,...
Mindera Health Announces Commercial Relocation
27 nov. 2023 08h00 HE
|
Mindera Health
San Diego, CA, Nov. 27, 2023 (GLOBE NEWSWIRE) -- Mindera Health™, a leading provider of precision medicine solutions for psoriasis, today announced that it will be relocating its commercial...
Mindera Health ™ announces the signing of a commercial agreement with Occum Health for Mind.Px ™
06 nov. 2023 08h00 HE
|
Mindera Health
San Diego, CA, Nov. 06, 2023 (GLOBE NEWSWIRE) -- Mindera Health today announces the signing a commercial agreement with Occum Health, LLC, a healthcare solutions company that is focused on...
Arcutis Announces Third Quarter 2023 Financial Results and Provides Business Update
03 nov. 2023 07h30 HE
|
Arcutis Biotherapeutics, Inc.
Arcutis today reported financial results for the quarter ended September 30, 2023, and provided a business update.
Mindera Inc. Signs Provider Contract with Provider Network Contigo Health ConfigureNet(™)
23 oct. 2023 08h00 HE
|
Mindera Health
San Diego, CA, Oct. 23, 2023 (GLOBE NEWSWIRE) -- Mindera Health™, the developer of Mind.Px, the first realization of precision medicine in psoriasis, announces that it has signed a provider contract...
Mindera Health™ Announces Issuance of Additional International Patent Coverage for Dermal Biomarker Patch Platform
16 oct. 2023 08h00 HE
|
Mindera Health
San Diego, CA, Oct. 16, 2023 (GLOBE NEWSWIRE) -- Mindera Health, a precision medicine company developing personalized tools to optimize patient outcomes, today announced that additional patent...
Mindera Health™ Announces Contract With General Services Administration®
10 oct. 2023 08h00 HE
|
Mindera Health
San Diego, CA, Oct. 10, 2023 (GLOBE NEWSWIRE) -- Mindera Health today announced that the General Services Administration (GSA) has granted a 5 year contract award to Mindera Health enabling access...
Scinai Immunotherapeutics Innovative Plaque Psoriasis Treatment Shows Encouraging Preclinical Results
13 sept. 2023 16h13 HE
|
Scinai Immunotherapeutics Ltd.
Scinai’s NanoAbs downregulated key molecular markers overexpressed in plaque psoriasis Stratum corneum regained normal appearance in laboratory 3D skin model Results from ex-vivo study...
With Little Remaining Unmet Need for Injectable Biologics for the Treatment of Plaque Psoriasis, US Dermatologists Report the Future is Oral, According to Spherix Global Insights
31 août 2023 16h35 HE
|
Spherix Global Insights
Exton, Pennsylvania, Aug. 31, 2023 (GLOBE NEWSWIRE) -- The biologic treatment armamentarium for plaque psoriasis has arguably experienced some of the most successful developments in recent...